Financing

Medis Group Revenue Growth

Strong and stable financial performance enables Medis to present a low level of risk to its business partners. Over the past five years, Medis has seen average revenue increases of nearly 16 percent per year, ending the 2020 fiscal year with revenues of €136.1 million, up 11.9 percent year-over-year.

Medis meets Dun & Bradstreet's highest financial credit rating criteria every year. Medis's Dun & Bradstreet rating is 4A1.

Platinum Excellence Award

For 2020, we have been officially recognized as one of Slovenia’s most reliable companies entitled to use the internationally recognized status of Platinum Excellence, a symbol of truly exceptional credit. This achievement is the result of an excellent team, state-of-the-art technology, and the desire to be better. We thank our partners, clients, and patients for placing their trust in us and recognizing us as a reliable partner in providing the region’s best possible medical solutions.

Medis is a reliable and credible business partner with a low risk level. The right level of business diversification, development strategy, and modern and accurate financial planning translates to financial strength. It is critical to balance development and long-term risk. Erna Slana Chief Finance Officer

What our partners say about us

We are always looking for innovative new products to improve the health of patients in our regions.
Our business development team is happy to help you in any stage of your inquiry.


Connect with us today.

Medis, d.o.o. Brnčičeva 1, 1000 Ljubljana
Slovenia